UNSPSC 51343302: Edoxudine

This classification denotes an antiviral agent with the molecular formula C11H16N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 15ZQM81Y3R, chemically known as uridine, 2-deoxy-5-ethyl- but generally known as edoxudine, which bears US NIH Compound Identifier 1814. European Medicines Agency schedules Edoxudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06460MIG.

UNSPSC 51343302 Edoxudine, a Commodity code, shows minimal relevant recent activity in state and local procurement. The code nominally describes a specific antiviral pharmaceutical, but the two most recent opportunities tagged under it involve unrelated pharmaceutical products: one Illinois Department of Public Health contract awards antibiotics (Doxycycline and Ciprofloxacin) through a piggyback piggyback arrangement, and one Seminole County, Florida solicitation sought Naloxone and drug deactivation systems for community health use. Neither opportunity involves Edoxudine or medications in the code's stated scope. State and local health agencies and counties issuing pharmaceutical procurements typically use cooperative purchasing agreements, piggyback contracts, and IFB processes to acquire medications at volume discounts, but the recent record does not establish active buying specifically under this commodity code.

The geographic presence indicated by recent records spans Florida and Illinois, though the two opportunities are not aligned with the code's nominal description. The Illinois Department of Public Health awarded a $2,999,999.11 contract over three years to Chartwell Rx LLC for antibiotic supply beginning August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392, completed award through MMCAP Infuse consortium). Seminole County posted an IFB on June 30, 2026 (IFB 60459723LAS, due July 26, 2026) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Neither opportunity represents active procurement under the Edoxudine commodity code; the mismatch suggests the code may be misapplied in state and local systems or that procurement under this specific pharmaceutical has not generated recent state and local solicitations.